Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality

A previously utilized quinoline-for-N-phenylamide replacement strategy was employed against a central amide in a novel class of CGRP receptor antagonists. A unique and unexpected substitution pattern was ultimately required to maintain reasonable affinity for the CGRP receptor, while at the same tim...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2010-11, Vol.20 (22), p.6827-6830
Main Authors: Wood, Michael R., Schirripa, Kathy M., Kim, June J., Bednar, Rodney A., Fay, John F., Bruno, Joseph G., Moore, Eric L., Mosser, Scott D., Roller, Shane, Salvatore, Christopher A., Vacca, Joseph P., Selnick, Harold G.
Format: Article
Language:English
Subjects:
Amides - chemistry
Amides - pharmacology
Antagonist
Biological and medical sciences
Calcitonin gene-related peptide
CGRP
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Receptors, Calcitonin Gene-Related Peptide - antagonists & inhibitors
Stereoisomerism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c385t-8eeb83fd154f16cb6365ed7a1aba56ba9628225e174d06cc730ef5237bebbaa03
cites cdi_FETCH-LOGICAL-c385t-8eeb83fd154f16cb6365ed7a1aba56ba9628225e174d06cc730ef5237bebbaa03
container_end_page 6830
container_issue 22
container_start_page 6827
container_title Bioorganic & medicinal chemistry letters
container_volume 20
creator Wood, Michael R.
Schirripa, Kathy M.
Kim, June J.
Bednar, Rodney A.
Fay, John F.
Bruno, Joseph G.
Moore, Eric L.
Mosser, Scott D.
Roller, Shane
Salvatore, Christopher A.
Vacca, Joseph P.
Selnick, Harold G.
description A previously utilized quinoline-for-N-phenylamide replacement strategy was employed against a central amide in a novel class of CGRP receptor antagonists. A unique and unexpected substitution pattern was ultimately required to maintain reasonable affinity for the CGRP receptor, while at the same time predicting acceptable heterocycle positioning for related analogs. Subsequently, specific quinoline and naphthyridine compounds were prepared which supported these structural predictions by displaying CGRP binding affinities in the 0.037–0.15nM range.
doi_str_mv 10.1016/j.bmcl.2010.08.105
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_759323650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X10012412</els_id><sourcerecordid>759323650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-8eeb83fd154f16cb6365ed7a1aba56ba9628225e174d06cc730ef5237bebbaa03</originalsourceid><addsrcrecordid>eNp9kc9rFDEYhoNY7Fr9BzxILuJptvk9M9CLLFqFUqVU8Ba-ZL6pWWYm02R2of-9WXbVW0-Bh-d9-XhDyDvO1pxxc7ldu9EPa8EKYE1h-gVZcWVUJRXTL8mKtYZVTat-nZPXOW8Z44op9YqcC9Zo1tZyRcJt3ONAN9d3P2hCj_MSE4VpgYc4hbxk2qc4Uo_TkmCgMIYOizcP4HEsMFMPuxymBwoF7zHlYsWezgl7TAk76n-HkgzL0xty1sOQ8e3pvSA_v3y-33ytbr5ff9t8uqm8bPRSNYiukX3Hteq58c5Io7GrgYMDbRy0RjRCaOS16pjxvpYMey1k7dA5ACYvyMdj75zi4w7zYseQPQ4DTBh32da6laKUHkxxNH2KOZeL7ZzCCOnJcmYPC9utPSxsDwtb1hSmS-j9qX7nRuz-Rf5OWoQPJwGyh6FPMPmQ_3tStlq0qnhXRw_LGPuAyWYfcPLYhfIRi-1ieO6OPwTKm4g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>759323650</pqid></control><display><type>article</type><title>Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality</title><source>ScienceDirect Journals</source><creator>Wood, Michael R. ; Schirripa, Kathy M. ; Kim, June J. ; Bednar, Rodney A. ; Fay, John F. ; Bruno, Joseph G. ; Moore, Eric L. ; Mosser, Scott D. ; Roller, Shane ; Salvatore, Christopher A. ; Vacca, Joseph P. ; Selnick, Harold G.</creator><creatorcontrib>Wood, Michael R. ; Schirripa, Kathy M. ; Kim, June J. ; Bednar, Rodney A. ; Fay, John F. ; Bruno, Joseph G. ; Moore, Eric L. ; Mosser, Scott D. ; Roller, Shane ; Salvatore, Christopher A. ; Vacca, Joseph P. ; Selnick, Harold G.</creatorcontrib><description>A previously utilized quinoline-for-N-phenylamide replacement strategy was employed against a central amide in a novel class of CGRP receptor antagonists. A unique and unexpected substitution pattern was ultimately required to maintain reasonable affinity for the CGRP receptor, while at the same time predicting acceptable heterocycle positioning for related analogs. Subsequently, specific quinoline and naphthyridine compounds were prepared which supported these structural predictions by displaying CGRP binding affinities in the 0.037–0.15nM range.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.08.105</identifier><identifier>PMID: 20850973</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Amides - chemistry ; Amides - pharmacology ; Antagonist ; Biological and medical sciences ; Calcitonin gene-related peptide ; CGRP ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Receptors, Calcitonin Gene-Related Peptide - antagonists &amp; inhibitors ; Stereoisomerism</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2010-11, Vol.20 (22), p.6827-6830</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-8eeb83fd154f16cb6365ed7a1aba56ba9628225e174d06cc730ef5237bebbaa03</citedby><cites>FETCH-LOGICAL-c385t-8eeb83fd154f16cb6365ed7a1aba56ba9628225e174d06cc730ef5237bebbaa03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23395294$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20850973$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wood, Michael R.</creatorcontrib><creatorcontrib>Schirripa, Kathy M.</creatorcontrib><creatorcontrib>Kim, June J.</creatorcontrib><creatorcontrib>Bednar, Rodney A.</creatorcontrib><creatorcontrib>Fay, John F.</creatorcontrib><creatorcontrib>Bruno, Joseph G.</creatorcontrib><creatorcontrib>Moore, Eric L.</creatorcontrib><creatorcontrib>Mosser, Scott D.</creatorcontrib><creatorcontrib>Roller, Shane</creatorcontrib><creatorcontrib>Salvatore, Christopher A.</creatorcontrib><creatorcontrib>Vacca, Joseph P.</creatorcontrib><creatorcontrib>Selnick, Harold G.</creatorcontrib><title>Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A previously utilized quinoline-for-N-phenylamide replacement strategy was employed against a central amide in a novel class of CGRP receptor antagonists. A unique and unexpected substitution pattern was ultimately required to maintain reasonable affinity for the CGRP receptor, while at the same time predicting acceptable heterocycle positioning for related analogs. Subsequently, specific quinoline and naphthyridine compounds were prepared which supported these structural predictions by displaying CGRP binding affinities in the 0.037–0.15nM range.</description><subject>Amides - chemistry</subject><subject>Amides - pharmacology</subject><subject>Antagonist</subject><subject>Biological and medical sciences</subject><subject>Calcitonin gene-related peptide</subject><subject>CGRP</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptors, Calcitonin Gene-Related Peptide - antagonists &amp; inhibitors</subject><subject>Stereoisomerism</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kc9rFDEYhoNY7Fr9BzxILuJptvk9M9CLLFqFUqVU8Ba-ZL6pWWYm02R2of-9WXbVW0-Bh-d9-XhDyDvO1pxxc7ldu9EPa8EKYE1h-gVZcWVUJRXTL8mKtYZVTat-nZPXOW8Z44op9YqcC9Zo1tZyRcJt3ONAN9d3P2hCj_MSE4VpgYc4hbxk2qc4Uo_TkmCgMIYOizcP4HEsMFMPuxymBwoF7zHlYsWezgl7TAk76n-HkgzL0xty1sOQ8e3pvSA_v3y-33ytbr5ff9t8uqm8bPRSNYiukX3Hteq58c5Io7GrgYMDbRy0RjRCaOS16pjxvpYMey1k7dA5ACYvyMdj75zi4w7zYseQPQ4DTBh32da6laKUHkxxNH2KOZeL7ZzCCOnJcmYPC9utPSxsDwtb1hSmS-j9qX7nRuz-Rf5OWoQPJwGyh6FPMPmQ_3tStlq0qnhXRw_LGPuAyWYfcPLYhfIRi-1ieO6OPwTKm4g</recordid><startdate>20101115</startdate><enddate>20101115</enddate><creator>Wood, Michael R.</creator><creator>Schirripa, Kathy M.</creator><creator>Kim, June J.</creator><creator>Bednar, Rodney A.</creator><creator>Fay, John F.</creator><creator>Bruno, Joseph G.</creator><creator>Moore, Eric L.</creator><creator>Mosser, Scott D.</creator><creator>Roller, Shane</creator><creator>Salvatore, Christopher A.</creator><creator>Vacca, Joseph P.</creator><creator>Selnick, Harold G.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101115</creationdate><title>Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality</title><author>Wood, Michael R. ; Schirripa, Kathy M. ; Kim, June J. ; Bednar, Rodney A. ; Fay, John F. ; Bruno, Joseph G. ; Moore, Eric L. ; Mosser, Scott D. ; Roller, Shane ; Salvatore, Christopher A. ; Vacca, Joseph P. ; Selnick, Harold G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-8eeb83fd154f16cb6365ed7a1aba56ba9628225e174d06cc730ef5237bebbaa03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Amides - chemistry</topic><topic>Amides - pharmacology</topic><topic>Antagonist</topic><topic>Biological and medical sciences</topic><topic>Calcitonin gene-related peptide</topic><topic>CGRP</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptors, Calcitonin Gene-Related Peptide - antagonists &amp; inhibitors</topic><topic>Stereoisomerism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wood, Michael R.</creatorcontrib><creatorcontrib>Schirripa, Kathy M.</creatorcontrib><creatorcontrib>Kim, June J.</creatorcontrib><creatorcontrib>Bednar, Rodney A.</creatorcontrib><creatorcontrib>Fay, John F.</creatorcontrib><creatorcontrib>Bruno, Joseph G.</creatorcontrib><creatorcontrib>Moore, Eric L.</creatorcontrib><creatorcontrib>Mosser, Scott D.</creatorcontrib><creatorcontrib>Roller, Shane</creatorcontrib><creatorcontrib>Salvatore, Christopher A.</creatorcontrib><creatorcontrib>Vacca, Joseph P.</creatorcontrib><creatorcontrib>Selnick, Harold G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wood, Michael R.</au><au>Schirripa, Kathy M.</au><au>Kim, June J.</au><au>Bednar, Rodney A.</au><au>Fay, John F.</au><au>Bruno, Joseph G.</au><au>Moore, Eric L.</au><au>Mosser, Scott D.</au><au>Roller, Shane</au><au>Salvatore, Christopher A.</au><au>Vacca, Joseph P.</au><au>Selnick, Harold G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-11-15</date><risdate>2010</risdate><volume>20</volume><issue>22</issue><spage>6827</spage><epage>6830</epage><pages>6827-6830</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>A previously utilized quinoline-for-N-phenylamide replacement strategy was employed against a central amide in a novel class of CGRP receptor antagonists. A unique and unexpected substitution pattern was ultimately required to maintain reasonable affinity for the CGRP receptor, while at the same time predicting acceptable heterocycle positioning for related analogs. Subsequently, specific quinoline and naphthyridine compounds were prepared which supported these structural predictions by displaying CGRP binding affinities in the 0.037–0.15nM range.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20850973</pmid><doi>10.1016/j.bmcl.2010.08.105</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6827-6830
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_759323650
source ScienceDirect Journals
subjects Amides - chemistry
Amides - pharmacology
Antagonist
Biological and medical sciences
Calcitonin gene-related peptide
CGRP
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Receptors, Calcitonin Gene-Related Peptide - antagonists & inhibitors
Stereoisomerism
title Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T03%3A24%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20CGRP%20receptor%20antagonists%20from%20central%20amide%20replacements%20causing%20a%20reversal%20of%20preferred%20chirality&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Wood,%20Michael%20R.&rft.date=2010-11-15&rft.volume=20&rft.issue=22&rft.spage=6827&rft.epage=6830&rft.pages=6827-6830&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.08.105&rft_dat=%3Cproquest_cross%3E759323650%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c385t-8eeb83fd154f16cb6365ed7a1aba56ba9628225e174d06cc730ef5237bebbaa03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=759323650&rft_id=info:pmid/20850973&rfr_iscdi=true